HTL14242 (oral administration; 1, 3, or 10 mg/kg; sacrificed 1 h postdose) emonstrates an excellent, dose-dependent occupancy of mGlu5 receptors from an oral dose, with an estimated ED50 of 0.3 mg/kg.
HTL14242 (oral administration; 1 mg/ml) exhibits an oral PK Profile, the t1/2, AUCinf and F% are 6.5 hours, 3946 ng/h/mL and 80%, respectively in dog.
| Animal Model: |
Dog (PK study) |
| Dosage: |
3, 10 and 30 mg/kg |
| Administration: |
Oral administration; single dose |
| Result: |
Had a good PK characteristics in dogs. |